These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 536337)

  • 1. Pharmacokinetics of tetroxoprim and sulphadiazine in human volunteers.
    Reeves DS; Broughall JM; Bywater MJ; Holt HA; Vergin H
    J Antimicrob Chemother; 1979 Nov; 5(B):119-38. PubMed ID: 536337
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of tetroxoprim and sulphadiazine in various species.
    Vergin H; Fritschi E
    J Antimicrob Chemother; 1979 Nov; 5(B):103-18. PubMed ID: 536336
    [No Abstract]   [Full Text] [Related]  

  • 3. HPLC determination of tetroxoprim and sulphadiazine in pharmaceutical dosage forms and in biological fluids.
    Springolo V; Coppi G
    J Pharm Biomed Anal; 1989; 7(1):57-65. PubMed ID: 2488608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tetroxoprim/sulphadiazine in patients with impaired renal function.
    Reutter FW; Vergin H; Sieber R; Ferber H
    J Antimicrob Chemother; 1979 Nov; 5(B):149-58. PubMed ID: 536339
    [No Abstract]   [Full Text] [Related]  

  • 5. [High-performance liquid chromatographic determination of tetroxoprim and sulfadiazine in biological samples (author's transl)].
    Vergin H; Bishop GB
    Arzneimittelforschung; 1980; 30(2):317-9. PubMed ID: 7378112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal elimination kinetics of tetroxoprim and sulfadiazine in patients with renal insufficiency].
    Vergin H; Reutter FW; Sieber R; Ferber H
    Arzneimittelforschung; 1980; 30(2):313-7. PubMed ID: 7378111
    [No Abstract]   [Full Text] [Related]  

  • 7. Tetroxoprim-sulphadiazine distribution in canine prostate.
    Nielsen OS; Iversen P; Vergin H; Madsen PO
    J Antimicrob Chemother; 1982 Mar; 9(3):240-2. PubMed ID: 7076606
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioequivalency studies on tablet formulation of tetroxoprim and sulphadiazine.
    Alkaysi HN; Salem MA; Gharaibeh AM; Gharaibeh KI; Badwan AA
    J Clin Pharm Ther; 1992 Apr; 17(2):97-9. PubMed ID: 1583085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the physiological availability and metabolism of sulfonamides. I. Sulfadiazine.
    Van Petten GR; Becking GC; Withey RJ; Lettau HF
    J Clin Pharmacol New Drugs; 1971; 11(1):27-34. PubMed ID: 4926393
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability of sulfadiazine solutions, suspensions, and tablets in humans.
    Meyer MC; Straughn AB; Ramachander G; Cavagnol JC; Biola Mabadeje AF
    J Pharm Sci; 1978 Dec; 67(12):1659-61. PubMed ID: 581498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diffusion of tetroxoprim and sulfadiazine in the cerebrospinal fluid of neurosurgery patients].
    Albert F; Bishop-Freudling GB; Vergin H
    Fortschr Med; 1984 Nov; 102(41):1064-6. PubMed ID: 6500470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas-liquid chromatographic determination of sulphadiazine and its major metabolite in human plasma and urine.
    Bye A; Land G
    J Chromatogr; 1977 Sep; 139(1):181-5. PubMed ID: 893610
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute renal failure due to sulphadiazine crystalluria in AIDS patients.
    de Sequera P; Albalate M; Hernandez J; Vazquez A; Abad J; Ramiro E; Fernández Guerrero M; Caramelo C; Casado S; Ortiz A
    Postgrad Med J; 1996 Sep; 72(851):557-8. PubMed ID: 8949595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary and renal excretion of sulphadiazine in goats.
    Atef M; Rasmussen F
    Zentralbl Veterinarmed A; 1975 Aug; 22(6):501-9. PubMed ID: 811018
    [No Abstract]   [Full Text] [Related]  

  • 15. High performance liquid chromatographic analysis of tetroxoprim and sulphadiazine in serum and urine.
    Alkaysi HN; Salem MS; Badwan AA
    Biomed Chromatogr; 1991 Nov; 5(6):265-8. PubMed ID: 1662101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of tetroxoprim in man.
    Korn A; Ferber H; Hitzenberger G; Vergin H
    J Antimicrob Chemother; 1979 Nov; 5(B):139-47. PubMed ID: 536338
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism of sulphadiazine in goats.
    Atef M; Nielsen P
    Xenobiotica; 1975 Mar; 5(3):167-72. PubMed ID: 1166664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open and comparative treatment studies with tetroxoprim/sulphadiazine combinations in urinary infections (1975--1979).
    Reeves DS; Bint AJ; Bowman R; Bullock DW; Elliott PJ; Hinton CE; Honeybourne D; Mojaddedi Z; Slade RR; Wilkinson PJ
    J Antimicrob Chemother; 1979 Nov; 5(B):179-88. PubMed ID: 395147
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of magnesium stearate on physical properties and biological availability of sulphadiazine tablet formulations.
    Ahmed M; Enever RP
    Pharm Acta Helv; 1978; 53(12):358-64. PubMed ID: 746045
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tetroxoprim-sulphadiazine in the treatment of typhoid fever].
    Sánchez Sevillano A; Cepeda Rodrigo JM; Pérez-Mateo M
    Med Clin (Barc); 1985 Nov; 85(15):642. PubMed ID: 4079552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.